X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (524) 524
male (327) 327
isoflurophate - pharmacology (290) 290
rats (267) 267
isoflurophate - toxicity (171) 171
female (143) 143
pharmacology & pharmacy (112) 112
time factors (104) 104
acetylcholinesterase - metabolism (91) 91
brain - drug effects (91) 91
neurosciences (89) 89
mice (88) 88
rats, inbred strains (88) 88
cholinesterase inhibitors - pharmacology (83) 83
humans (81) 81
brain - enzymology (79) 79
isoflurophate (79) 79
toxicology (77) 77
isoflurophate - administration & dosage (74) 74
chickens (72) 72
dfp (65) 65
atropine - pharmacology (62) 62
dose-response relationship, drug (62) 62
index medicus (61) 61
in vitro techniques (60) 60
brain - metabolism (56) 56
cholinesterase inhibitors - toxicity (56) 56
diisopropylfluorophosphate (53) 53
acetylcholinesterase (50) 50
brain (47) 47
kinetics (43) 43
behavior, animal - drug effects (42) 42
receptors, muscarinic - drug effects (39) 39
drug tolerance (38) 38
rats, sprague-dawley (37) 37
biochemistry & molecular biology (36) 36
cholinesterases - metabolism (36) 36
motor activity - drug effects (36) 36
organophosphate (36) 36
physostigmine - pharmacology (35) 35
cholinesterase inhibitors (33) 33
acetylcholine (31) 31
carboxylic ester hydrolases - antagonists & inhibitors (29) 29
cats (29) 29
soman (29) 29
isoflurophate - antagonists & inhibitors (28) 28
isoflurophate - poisoning (27) 27
rat (27) 27
acetylcholine - metabolism (26) 26
body temperature - drug effects (26) 26
rats, wistar (26) 26
lethal dose 50 (25) 25
organophosphates (25) 25
organophosphorus compounds - toxicity (25) 25
tolerance (25) 25
cholinesterases - blood (24) 24
guinea pigs (24) 24
inhibition (24) 24
isoflurophate - analogs & derivatives (24) 24
atropine (23) 23
diisopropyl fluorophosphate (23) 23
spinal cord - drug effects (23) 23
acetylcholine - pharmacology (22) 22
carbachol - pharmacology (22) 22
drug interactions (22) 22
enzyme inhibitors (22) 22
injections, subcutaneous (22) 22
isoflurophate - metabolism (22) 22
receptors, muscarinic - metabolism (22) 22
adult (21) 21
article (21) 21
carboxylic ester hydrolases - metabolism (21) 21
cholinesterase (21) 21
disease models, animal (21) 21
muscarinic receptors (21) 21
organophosphorus compounds (21) 21
rabbits (21) 21
neurons - drug effects (20) 20
pralidoxime compounds - pharmacology (20) 20
corpus striatum - metabolism (19) 19
muscle contraction - drug effects (19) 19
receptors, cholinergic - drug effects (19) 19
species specificity (19) 19
toxicity (19) 19
neurotoxicity (18) 18
seizures (18) 18
cholinesterase inhibitors - administration & dosage (17) 17
depression, chemical (17) 17
phosphates (17) 17
seizures - chemically induced (17) 17
diisopropyl phosphorofluoridate (16) 16
induced delayed neurotoxicity (16) 16
neurology (16) 16
neurons (16) 16
swine (16) 16
acetylcholinesterase - analysis (15) 15
brain - pathology (15) 15
brain chemistry - drug effects (15) 15
hydrolysis (15) 15
liver - enzymology (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bulletin of Experimental Biology and Medicine, ISSN 0007-4888, 6/2018, Volume 165, Issue 2, pp. 225 - 229
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 04/2009, Volume 145, Issue 2, pp. 245 - 254
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2010, Volume 148, Issue 3, pp. 466 - 475
Summary Cardiac and endocrine disorders are common sequelae of iron overload in transfused thalassaemia patients. Combined chelation with desferrioxamine (DFO)... 
iron overload | thalassaemia | endocrinopathy | cardiomyopathy | combined chelation | Endocrinopathy | Iron overload | Thalassaemia | Combined chelation | Cardiomyopathy | CARDIOVASCULAR MAGNETIC-RESONANCE | HEART-FAILURE | INSULIN SENSITIVITY | TRANSFUSION-DEPENDENT THALASSEMIA | GLUCOSE-METABOLISM | MYOCARDIAL SIDEROSIS | SUBCLINICAL THYROID-DYSFUNCTION | BETA-THALASSEMIA | HEMATOLOGY | NORMOGLYCEMIC PATIENTS | COMBINED THERAPY | Follow-Up Studies | Iron Overload - drug therapy | Humans | Thyroxine - administration & dosage | Endocrine System Diseases - etiology | Deferoxamine - therapeutic use | Male | beta-Thalassemia - complications | Deferoxamine - adverse effects | Cardiomyopathies - etiology | Iron Overload - blood | Young Adult | Ferritins - blood | Adult | Female | Drug Therapy, Combination | Child | Endocrine System Diseases - drug therapy | Cardiomyopathies - drug therapy | Iron Chelating Agents - therapeutic use | beta-Thalassemia - therapy | Drug Administration Schedule | Liver - metabolism | Hypothyroidism - etiology | Iron Chelating Agents - adverse effects | Transfusion Reaction | Iron Overload - complications | Adolescent | Hypothyroidism - drug therapy | Pyridones - therapeutic use | Blood Glucose - metabolism | Pyridones - adverse effects | Testosterone | Complications and side effects | Glucose metabolism | Cardiac patients | Thyroxine | Ferritin | Isoflurophate | Iron | Glucose | Hypothyroidism | Dextrose
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 2009, Volume 42, Issue 3, pp. 247 - 251
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 2009, Volume 240, Issue 2, pp. 124 - 131
Prophylactic agents acutely administered in response to anticholinesterases intoxication can prevent toxic symptoms, including fasciculations, seizures,... 
Oxidative stress | Neurotoxicity | Memantine | Neurodegeneration | Vitamin E | Biomarkers | Dendritic system | PBN | DFP | TERT-BUTYL NITRONE | ACID-INDUCED EXCITOTOXICITY | ALPHA-TOCOPHEROL | SOMAN-INDUCED SEIZURES | CYTOCHROME-C-OXIDASE | IN-VIVO | NITRIC-OXIDE | ENERGY METABOLITES | PHARMACOLOGY & PHARMACY | TOXICOLOGY | INDUCED STATUS EPILEPTICUS | SPIN-TRAPPING AGENTS | Vitamin A - pharmacology | Pyramidal Cells - metabolism | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Seizures - prevention & control | Neurodegenerative Diseases - prevention & control | Male | Seizures - chemically induced | Brain - metabolism | Neuroprotective Agents - pharmacology | Neurotoxicity Syndromes - pathology | Time Factors | Cyclic N-Oxides - pharmacology | Lipid Peroxidation - drug effects | Pyramidal Cells - drug effects | Neuroprotective Agents - administration & dosage | Disease Models, Animal | Biomarkers - metabolism | Memantine - pharmacology | Cholinesterase Inhibitors | Neurodegenerative Diseases - pathology | Injections, Intraperitoneal | Excitatory Amino Acid Antagonists - administration & dosage | Rats | Neurotoxicity Syndromes - prevention & control | Excitatory Amino Acid Antagonists - pharmacology | Antioxidants - pharmacology | Neurodegenerative Diseases - metabolism | Rats, Sprague-Dawley | Brain - drug effects | Neurotoxicity Syndromes - etiology | Animals | Neurodegenerative Diseases - chemically induced | Antioxidants - administration & dosage | Brain - pathology | Neurotoxicity Syndromes - metabolism | Isoflurophate | Oxidative Stress - drug effects | Index Medicus | DENDRITES | OXIDATION | ANTIOXIDANTS | CEREBRUM | RATS | TOXICITY | 60 APPLIED LIFE SCIENCES | DAMAGE | STRESSES | CITRULLINE | BIOLOGICAL MARKERS | VERTEBRAE | PREVENTIVE MEDICINE | RECEPTORS | NERVE CELLS | VITAMIN E
Journal Article
Toxicological Sciences, ISSN 1096-6080, 2011, Volume 120, Issue 1, pp. 136 - 145
Journal Article
Toxicology, ISSN 0300-483X, 2008, Volume 256, Issue 3, pp. 164 - 174
Journal Article